From collaborators to a complete exit: The 16-year alliance between #Biocon and Mylan has officially come full circle. What began as a licensing pact in 2009 evolved into a $3B equity partnership in 2022, before Viatris' final stake sale in July 2026. Here is a q – LinkedIn